Efficacy analysis by disease risk subgroup for the phase 3 athena-mono study (GOG-3020/engot-OV45) evaluating rucaparib maintenance treatment in patients with newly diagnosed ovarian cancer

Bibliographische Detailangaben

Hauptverfasser:	O'Malley, David, Christopoulou, Athina, Lim, Myong Cheol, Diaz, John, Demirkiran, Fuat, Wilson, Michelle, Jewell, Andrea, Drochýtek, Vít, Bessette, Paul, Morris, Robert, Van Gorp, Toon, Van Le, Linda, Lindahl, Gabriel, Eskander, Ramez, Collins, Dearbhaile, Goble, Sandra, Hume, Stephanie, Fujiwara, Keiichi, Monk, Bradley, Kristeleit, Rebecca
Format:	Other
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!